(MENAFN- GlobeNewsWire - Nasdaq)
Investors can contact the law firm at no cost to learn more about recovering their losses
LOS ANGELES, Jan. 24, 2023 (GLOBE NEWSWIRE) -- the portnoy law firm advises Surmodics, Inc (“Surmodics” or“the Company”) (NASDAQ: SRDX) investors that the firm has initiated an investigation into possible securities fraud and may file a class action on behalf of investors. Surmodics investors that lost money on their investment are encouraged to contact Lesley Portnoy, Esq.
Investors are encouraged to contact attorney lesley f. portnoy , by phone 844-767-8529 or email : , to discuss their legal rights, or click here to join the case via . The Portnoy Law Firm can provide a complimentary case evaluation and discuss investors' options for pursuing claims to recover their losses.
The investigation is looking into whether Surmodics, the company, made false and/or misleading statements and/or failed to disclose important information to its investors. On January 19, 2023, the company announced that it had received a letter from the FDA stating that the approval for their drug-coated balloon (DCB) product, SurVeilTM, could not be approved in its current form and that additional information on biocompatibility and labeling must be provided before approval. In response to the FDA letter, the company stated that they are evaluating the issues raised and plan to meet with the FDA to determine the next steps. They also mentioned that they will be evaluating options to reduce their use of cash due to this development. As a result of this news, the company's shares fell by over 28.3%.
Please visit our website to review more information and submit your transaction information.
The Portnoy Law Firm represents investors in pursuing claims against caused by corporate wrongdoing. The Firm's founding partner has recovered over $5.5 billion for aggrieved investors. Attorney advertising. Prior results do not guarantee similar outcomes.
Lesley F. Portnoy, Esq.
Admitted CA and NY Bar
Tags $srdx class action Related Links
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.